Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-11-000532
Filing Date
2011-01-28
Accepted
2011-01-28 18:53:46
Documents
1
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 c64180.html 5  
1 c64180.xml 5 3216
  Complete submission text file 0000930413-11-000532.txt   5375
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARMACEUTICALS INC. RTE 202/206 BRIDGEWATER NJ 08807
Business Address
del Campo Ralph (Reporting) CIK: 0001323683 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-12957 | Film No.: 11557199